GetTopicDetailResponse(id=73ca8396161, topicName=胰腺導(dǎo)管癌, introduction=胰腺導(dǎo)管癌, content=null, image=null, comments=2, allHits=1744, url=https://h5.medsci.cn/topic?id=83961, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=93350, tagList=[TagDto(tagId=93350, tagName=胰腺導(dǎo)管癌)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2253551, encodeId=e74b2253551d4, content=<a href='/topic/show?id=73ca8396161' target=_blank style='color:#2F92EE;'>#胰腺導(dǎo)管癌#</a> <a href='/topic/show?id=966e124602b8' target=_blank style='color:#2F92EE;'>#化療劑量密度#</a>, objectTitle=總生存期翻3倍！ 新研究揭示，攻克“癌王”，化療夠量效果才更好, objectType=article, longId=864568, objectId=f16686456884, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220906/1662451499353_5552845.jpg, objectUrl=/article/show_article.do?id=f16686456884, replyNumber=0, likeNumber=36, createdTime=2025-02-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=f16686456884, moduleTitle=總生存期翻3倍！ 新研究揭示，攻克“癌王”，化療夠量效果才更好, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f16686456884)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2173247, encodeId=338421e3247e9, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a> <a href='/topic/show?id=35c21222496' target=_blank style='color:#2F92EE;'>#mRNA#</a> <a href='/topic/show?id=73ca8396161' target=_blank style='color:#2F92EE;'>#胰腺導(dǎo)管癌#</a>, objectTitle=攻克“癌王”的潛在利器有哪些？Cancer重磅：盤點(diǎn)胰腺癌“最關(guān)鍵”治療進(jìn)展, objectType=article, longId=803621, objectId=f5ae8036212b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=f5ae8036212b, replyNumber=0, likeNumber=142, createdTime=2023-12-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f5ae8036212b, moduleTitle=攻克“癌王”的潛在利器有哪些？Cancer重磅：盤點(diǎn)胰腺癌“最關(guān)鍵”治療進(jìn)展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f5ae8036212b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1936009, encodeId=3167193600953, content=<a href='/topic/show?id=73ca8396161' target=_blank style='color:#2F92EE;'>#胰腺導(dǎo)管癌#</a>, objectTitle=JAMA Oncol：臨界可切除的胰腺導(dǎo)管癌的最佳新輔助治療策略, objectType=article, longId=732665, objectId=1bb8e32665e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bb8e32665e5, replyNumber=0, likeNumber=0, createdTime=2022-11-11, rootId=0, userName=ms2694732865965676, userId=c44f2500101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bb8e32665e5, moduleTitle=JAMA Oncol：臨界可切除的胰腺導(dǎo)管癌的最佳新輔助治療策略, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1bb8e32665e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1936008, encodeId=b712193600859, content=<a href='/topic/show?id=73ca8396161' target=_blank style='color:#2F92EE;'>#胰腺導(dǎo)管癌#</a>, objectTitle=CLIN CANCER RES：DNA損傷修復(fù)基因突變與接受FOLFIRINOX治療的胰腺導(dǎo)管癌患者預(yù)后改善有關(guān), objectType=article, longId=156364, objectId=7f2a1563646d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f2a1563646d, replyNumber=0, likeNumber=135, createdTime=2019-10-10, rootId=0, userName=ms2694732865965676, userId=c44f2500101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f2a1563646d, moduleTitle=CLIN CANCER RES：DNA損傷修復(fù)基因突變與接受FOLFIRINOX治療的胰腺導(dǎo)管癌患者預(yù)后改善有關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7f2a1563646d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
